Cardiac Rehabilitation in Severe Heart Failure Patients with Impella 5.0 Support via the Subclavian Artery Approach Prior to Left Ventricular Assist Device Implantation

Author:

Shimizu Miho12,Hiraiwa Hiroaki3ORCID,Tanaka Shinya1ORCID,Tsuchikawa Yohei1,Ito Ryota3,Kazama Shingo3,Kimura Yuki3,Araki Takashi3,Mizutani Takashi3,Oishi Hideo3,Kuwayama Tasuku3,Kondo Toru3ORCID,Morimoto Ryota3,Okumura Takahiro3ORCID,Ito Hideki4,Yoshizumi Tomo4,Mutsuga Masato4,Usui Akihiko4,Murohara Toyoaki3

Affiliation:

1. Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan

2. Department of Rehabilitation, Mie University Hospital, Tsu 514-8507, Japan

3. Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

4. Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

Abstract

Impella 5.0 circulatory support via subclavian artery (SA) access may be a safe approach for patients undergoing cardiac rehabilitation (CR). In this case series, we retrospectively analyzed the demographic characteristics, physical function, and CR data of six patients who underwent Impella 5.0 implantation via the SA prior to left ventricular assist device (LVAD) implantation between October 2013 and June 2021. The median age was 48 years, and one patient was female. Grip strength was maintained or increased in all patients before LVAD implantation (pre-LVAD) compared to after Impella 5.0 implantation. The pre-LVAD knee extension isometric strength (KEIS) was less than 0.46 kgf/kg in two patients and more than 0.46 kgf/kg in three patients (unavailable KEIS data, n = 1). With Impella 5.0 implantation, two patients could ambulate, one could stand, two could sit on the edge of the bed, and one remained in bed. One patient lost consciousness during CR due to decreased Impella flow. There were no other serious adverse events. Impella 5.0 implantation via the SA allows mobilization, including ambulation, prior to LVAD implantation, and CR can be performed relatively safely.

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3